ClinicalTrials.gov
public full text
Public Domain
Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid Arthritis
The primary objective of this study is to assess the safety (by collecting adverse events and serious adverse events) of adalimumab administered every other week to patients with moderately to severly active rheumatoid arthritis who have failed prior disease-modifying anti-rheumatic drugs (DMARDs).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Positron Emission Tomography in Rheumatoid Arthritis With Adalimumab (PETRA)#806853
- Study of Antibodies to Anti-TNF Agents in Juvenile Idiopathic Arthritis#841872
- Real-life Experience of Tofacitinib in Patients With Treatment-Resistant Rheumatoid Arthritis#1075367
- Anti-TNF Agents for the Treatment of Rheumatoid Arthritis#67691
- French National Registry: ART REGISTRY (Observational Study)#1152553
Record · ID 1165237
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive